ABCELLERA BIOLOGICS INC's ticker is ABCL and the CUSIP is 00288U106. A total of 131 filers reported holding ABCELLERA BIOLOGICS INC in Q1 2022. The put-call ratio across all filers is 0.31 and the average weighting 1.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,914,419 | +17.4% | 416,178 | +64.9% | 0.00% | – |
| Q2 2023 | $1,630,762 | -93.6% | 252,440 | -92.6% | 0.00% | -100.0% |
| Q1 2023 | $25,559,130 | -61.4% | 3,389,805 | -48.2% | 0.00% | -50.0% |
| Q4 2022 | $66,237,780 | +108.6% | 6,538,774 | +103.6% | 0.00% | 0.0% |
| Q3 2022 | $31,755,000 | -6.7% | 3,210,819 | +0.5% | 0.00% | 0.0% |
| Q2 2022 | $34,019,000 | +1197.0% | 3,194,309 | +1087.3% | 0.00% | – |
| Q1 2022 | $2,623,000 | +2.3% | 269,030 | +50.1% | 0.00% | – |
| Q4 2021 | $2,563,000 | +1.1% | 179,207 | +41.7% | 0.00% | – |
| Q3 2021 | $2,534,000 | – | 126,468 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Founders Fund VII Management, LLC | 3,773,530 | $37,320,000 | 92.58% |
| Gruss & Co., LLC | 308,570 | $3,052,000 | 26.27% |
| Founders Fund Growth Management, LLC | 407,017 | $4,025,000 | 11.55% |
| Belmont Capital, LLC | 510,000 | $5,044,000 | 5.95% |
| HARVARD MANAGEMENT CO INC | 4,105,095 | $40,599,000 | 5.05% |
| GUARDIAN CAPITAL ADVISORS LP | 3,736,414 | $40,129,000 | 5.01% |
| Intellectus Partners, LLC | 1,091,505 | $10,795,000 | 3.84% |
| ArchPoint Investors | 617,213 | $6,104,000 | 2.49% |
| BRANDYWINE MANAGERS, LLC | 56,976 | $563,000 | 1.85% |
| Casdin Capital, LLC | 1,650,000 | $16,319,000 | 1.07% |